Pharmacological approaches to cardio-renal syndrome: a role for the inodilator levosimendan

Clicks: 137
ID: 270908
2017
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Pathological interplay between the heart and kidneys-also known as cardio-renal syndrome (CRS)-is frequently encountered in heart failure and is linked to worse prognosis and quality of life. Drug therapies for this complex situation may include nitroprusside or the recombinant B-type natriuretic pe …
Reference Key
f2017europeanpharmacological Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Fedele F;Karason K;Matskeplishvili S;;
Journal European heart journal supplements : journal of the European Society of Cardiology
Year 2017
DOI
DOI not found
URL
https://www.ncbi.nlm.nih.gov/pubmed/29249907
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE pubmed abstract nih national institutes of health national library of medicine pmid:29249907 pmc5932558 doi:10.1093/eurheartj/sux002 francesco fedele kristjan karason simon matskeplishvili

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.